{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:48Z","timestamp":1786118988342,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/mot.0b013e3283186b80","type":"journal-article","created":{"date-parts":[[2008,11,20]],"date-time":"2008-11-20T03:10:15Z","timestamp":1227150615000},"page":"575-580","source":"Crossref","is-referenced-by-count":12,"title":["Granulocyte colony-stimulating factor, granulocyte\u2013macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients"],"prefix":"10.1097","volume":"13","author":[{"given":"Andrea V","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Conrad","family":"Liles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1600-6143.2006.01694.x","article-title":"Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group","volume":"7","author":"San Juan","year":"2007","journal-title":"Am J Transplant"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/340221","article-title":"Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor; granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-\u03b3","volume":"185","author":"Hubel","year":"2002","journal-title":"J Infect Dis"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1182\/blood-2007-07-097543","article-title":"Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges","volume":"111","author":"Anderlini","year":"2008","journal-title":"Blood"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood.V84.6.1737.1737","article-title":"Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization","volume":"84","author":"Lieschke","year":"1994","journal-title":"Blood"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation: challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1034\/j.1399-3062.1999.010310.x","article-title":"A 42-year-old lung transplant patient with ganciclovir-resistant cytomegalovirus (CMV) infection","volume":"1","author":"Basgoz","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Kuderer","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-4-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s004670050393","article-title":"Treatment of neutropenia in a renal transplant recipient with granulocyte colony-stimulating factor","volume":"12","author":"Moghal","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0022-3468(94)90079-5","article-title":"Effect of granulocyte colony-stimulating factor on neutropenia in liver transplant recipients with hypersplenism","volume":"29","author":"Ishizone","year":"1994","journal-title":"J Pediatr Surg"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007890-200002270-00011","article-title":"Recombinant human granulocyte colony-stimulating factor after kidney transplantation: a retrospective analysis to evaluate the benefit or risk of immunostimulation","volume":"69","author":"Schmaldienst","year":"2000","journal-title":"Transplantation"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1399-3062.2000.020104.x","article-title":"Safety and efficacy of granulocyte colony-stimulating factor in kidney and liver transplant recipients","volume":"2","author":"Turgeon","year":"2000","journal-title":"Transplant Infect Dis"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4049\/jimmunol.149.3.918","article-title":"Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-\u03b1","volume":"149","author":"Gorgen","year":"1992","journal-title":"J Immunol"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jsre.1996.0128","article-title":"Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis","volume":"61","author":"Dunne","year":"1996","journal-title":"J Surg Res"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/513812","article-title":"Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice","volume":"177","author":"Kullberg","year":"1998","journal-title":"J Infect Dis"},{"key":"R16-4-20210206","first-page":"2525","article-title":"Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria","volume":"91","author":"Held","year":"1998","journal-title":"Blood"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.159.5.9806082","article-title":"G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects","volume":"159","author":"Karzai","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/AAC.49.9.3668-3675.2005","article-title":"Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice","volume":"49","author":"Stearne","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-8-55","article-title":"Differential effects of antibiotics in combination with G-CSF on survival and polymorphonuclear granulocyte cell functions in septic rats","volume":"8","author":"Bauhofer","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.CCM.0B013E318161E480","article-title":"Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock","volume":"36","author":"Stephens","year":"2008","journal-title":"Crit Care Med"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2337\/diacare.28.2.454","article-title":"Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis","volume":"28","author":"Cruciani","year":"2005","journal-title":"Diabetes Care"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.61.11.4870-4877.1993","article-title":"Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon","volume":"61","author":"Roilides","year":"1993","journal-title":"Infect Immun"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/314728","article-title":"Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo","volume":"179","author":"Gaviria","year":"1999","journal-title":"J Infect Dis"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/513961","article-title":"Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens","volume":"175","author":"Liles","year":"1997","journal-title":"J Infect Dis"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3062.1999.010303.x","article-title":"Neutrophil respiratory burst following liver transplantation: in vitro effects of granulocyte colony-stimulating factor","volume":"1","author":"Jaeger","year":"1999","journal-title":"Transplant Infect Dis"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00007890-199911150-00014","article-title":"Randomized, placebo-controlled, double-blind, multicenter trial of efficacy and safety of granulocyte colony-stimulating factor in liver transplant recipients","volume":"68","author":"Winston","year":"1999","journal-title":"Transplantation"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nature Rev Immunol"},{"key":"R29-4-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/314361a0","article-title":"Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator","volume":"314","author":"Weisbart","year":"1985","journal-title":"Nature"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0","article-title":"Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers","volume":"57","author":"Dale","year":"1998","journal-title":"Am J Hematol"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon-\u03b3 and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important Zygomycetes","volume":"191","author":"Gil-Lamaignere","year":"2005","journal-title":"J Infect Dis"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2567.1998.00390.x","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on the number of leucocytes and course of Listeria monocytogenes infection in na\u00efve and leucocytopenic mice","volume":"93","author":"Buisman","year":"1998","journal-title":"Immunology"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jlb.50.3.296","article-title":"Colony-stimulating factors increase resistance to atypical mycobacteria in resistant mice, whereas they decrease resistance in susceptible strains of mice","volume":"50","author":"Denis","year":"1991","journal-title":"J Leuk Biol"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/eji.1830181009","article-title":"Application of recombinant granulocyte\u2013macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis","volume":"18","author":"Griel","year":"1988","journal-title":"Eur J Immunol"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood.V83.10.2893.2893","article-title":"Effect of granulocyte\u2013macrophage colony-stimulating factor on sepsis-induced organ injury in rats","volume":"83","author":"Toda","year":"1994","journal-title":"Blood"},{"issue":"Suppl 2","key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/BF01973596","article-title":"Prediction of the role of granulocyte\u2013macrophage colony-stimulating factor in animals and man from in vitro results","volume":"13","author":"Liehl","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/AAC.44.12.3328-3336.2000","article-title":"Recombinant murine granulocyte\u2013macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice","volume":"44","author":"Deepe","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-4-20210206","doi-asserted-by":"crossref","first-page":"38801","DOI":"10.1128\/AAC.48.10.3801-3805.2004","article-title":"Antifungal activities of posaconazole and granulocyte\u2013macrophage colony-stimulating factor ex-vivo and in mice with disseminated infection due to Scedosporium prolificans","volume":"48","author":"Simitsopoulou","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-4-20210206","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.00760-07","article-title":"Intranasal granulocyte\u2013macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis","volume":"52","author":"Quezada","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-4-20210206","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s001340050911","article-title":"GM-CSF increases in vitro the respiratory burst of human neutrophils after liver transplantation","volume":"25","author":"Jaeger","year":"1999","journal-title":"Intensive Care Med"},{"key":"R41-4-20210206","doi-asserted-by":"crossref","first-page":"938","DOI":"10.4049\/jimmunol.171.2.938","article-title":"GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro","volume":"171","author":"Xu","year":"2003","journal-title":"J Immunol"},{"key":"R42-4-20210206","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.tp.0000199269.77248.2f","article-title":"Nonspecific immunoglobulin and granulocyte\u2013macrophage colony-stimulating factor use in complicated varicella zoster: the first case report in a renal transplant recipient","volume":"81","author":"Vales-Albertos","year":"2006","journal-title":"Transplantation"},{"key":"R43-4-20210206","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0168-8278(98)80356-5","article-title":"Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation","volume":"28","author":"Trindade","year":"1998","journal-title":"J Hepatol"},{"key":"R44-4-20210206","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/S0041-1345(97)00779-3","article-title":"Use of rHu GM-CSF in renal-transplant patients developing leucopenia","volume":"29","author":"Hashmi","year":"1997","journal-title":"Transplant Proc"},{"key":"R45-4-20210206","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1378\/chest.127.6.2139","article-title":"Effect of granulocyte\u2013monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients","volume":"127","author":"Rosenbloom","year":"2005","journal-title":"Chest"},{"key":"R46-4-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0928-8244(03)00035-X","article-title":"Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia","volume":"15","author":"Roilides","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R47-4-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/cyto.1996.0006","article-title":"Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens","volume":"8","author":"Roilides","year":"1996","journal-title":"Cytokine"},{"key":"R48-4-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cyto.2001.0889","article-title":"Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus","volume":"15","author":"Gonzalez","year":"2001","journal-title":"Cytokine"},{"key":"R49-4-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/AAC.44.1.19-23.2000","article-title":"Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection","volume":"44","author":"Kuhara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R50-4-20210206","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1997.15.8.2954","article-title":"Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study","volume":"15","author":"Ohno","year":"1997","journal-title":"J Clin Oncol"},{"key":"R51-4-20210206","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood.V82.5.1422.1422","article-title":"Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor","volume":"82","author":"Nemunaitis","year":"1993","journal-title":"Blood"},{"key":"R52-4-20210206","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ndt\/gfh257","article-title":"Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection","volume":"19","author":"Le Meur","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R53-4-20210206","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.TP.0000100483.41935.B5","article-title":"Macrophage colony-stimulating factor inhibits tumor necrosis factor production and prolongs skin graft survival","volume":"77","author":"Nishina","year":"2004","journal-title":"Transplantation"},{"key":"R54-4-20210206","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/JVI.01571-06","article-title":"Inhibitory effect of gamma interferon on BK virus gene expression and replication","volume":"81","author":"Abend","year":"2007","journal-title":"J Virol"},{"key":"R55-4-20210206","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/168.2.436","article-title":"Recombinant interferon-\u03b3 enhances resistance to acute disseminated Candida albicans infection in mice","volume":"168","author":"Kullberg","year":"1993","journal-title":"J Infect Dis"},{"key":"R56-4-20210206","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J Infect Dis"},{"key":"R57-4-20210206","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V89.9.3396","article-title":"Dose-dependent enhancements by interferon-\u03b3 on functional responses of neutrophils from chronic granulomatous disease patients","volume":"89","author":"Ahlin","year":"1997","journal-title":"Blood"},{"key":"R58-4-20210206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group","volume":"324","author":"Gallin","year":"1991","journal-title":"N Engl J Med"},{"key":"R59-4-20210206","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.transproceed.2005.08.031","article-title":"Value of pretransplantation cytokine profiles for predicting acute rejection in renal transplant recipients","volume":"37","author":"Lessan-Pezeshki","year":"2005","journal-title":"Transplant Proc"},{"key":"R60-4-20210206","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-0012.1999.130208.x","article-title":"Expression of \u03b3-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients","volume":"13","author":"Moudgil","year":"1999","journal-title":"Clin Transplant"},{"key":"R61-4-20210206","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-0012.2007.00665.x","article-title":"Evidence for IFN-\u03b3 up- and IL-4 downregulation late posttransplant in patients with good kidney graft outcome","volume":"21","author":"Sadeghi","year":"2007","journal-title":"Clin Transplant"},{"key":"R62-4-20210206","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/TP.0b013e3181806a60","article-title":"Interferon-\u03b3 conditioning ex-vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy","volume":"86","author":"Feng","year":"2008","journal-title":"Transplantation"},{"key":"R63-4-20210206","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1600-6143.2007.01960.x","article-title":"Role of IFN-\u03b3 in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells","volume":"7","author":"Thebault","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOT.0b013e3283186b80","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:31Z","timestamp":1786036471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075200-200812000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283186b80","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}